PMS2 and colorectal cancer: They confirmed a low incidence of MMR deficiency, reporting that 2.9% of specimens harbored any mutation in at least one of the MMR genes (MLH1, PMS2, MSH2, and MSH6) as well as a low frequency of driver mutation as compared to colorectal cancer (29).